Life Sciences
The acquisition will enable Verily to build out its clinical trial platform, Baseline, which houses technology for decentralized and hybrid trials.
MobiHealthNews talks with AstraZeneca’s chief commercial digital officer about partnerships, COVID-19 and what's next for digital health.
HIMSS21
Industry leaders discussed the state of healthcare data analytics today at HIMSS21.
The study will look at how intensive non-surgical periodontal therapy and home dental hygiene impact overall health.
The researchers created a statistical method that extracts a person's circadian rhythm based on heart rate data provided by their smartwatch.
Its new onboarding platform builds on the Castor eConsent tool and leads participants through the recruitment, screening, consent and enrollment processes.
The companies will combine their complementary pathology tools to leverage services for tech-enabled diagnostics, drug discovery and patient care.
With HingeConnect, the platform has access to EMR data from 750,000 providers across 71,000 care sites to identify opportunities to offer users alternative care options.
Also: Maven welcomes its first CMO, Flume Health adds Haven alum as COO and Nexben hires CTO.
Valo’s flagship product is its Opal Computational Platform, designed to create a new model for drug discovery.